Novel CYP2C9 and VKORC1 gene variants associated with warfarin dosage variability in the South African black population

被引:1
|
作者
Mitchell, Cathrine [1 ,2 ]
Gregersen, Nerine [1 ,2 ]
Krause, Amanda [1 ,2 ]
机构
[1] Univ Witwatersrand, Div Human Genet, Natl Hlth Lab Serv, Johannesburg, South Africa
[2] Univ Witwatersrand, Sch Pathol, Johannesburg, South Africa
关键词
CYP2C9; VKORC1; warfarin; PHARMACODYNAMIC RESISTANCE; AMERICANS; PHARMACOGENETICS; ANTICOAGULATION; CYP2C9-ASTERISK-8; POLYMORPHISMS; HAPLOTYPES; DIVERSITY; DISCOVERY; GENOTYPE;
D O I
10.2217/PGS.11.36
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aim: Warfarin is a widely used therapeutic agent for long-term oral anticoagulation worldwide. Its administration is challenging owing to its narrow therapeutic range and serious adverse effects. Several environmental factors and numerous genes, of which CYP2C9 and VKORC1 are the most important, have been associated with interindividual dosage variability. Many studies have been conducted to understand warfarin dosage variability better, the majority of which have been focused on the Caucasian and African-American populations. Very little information is available regarding genetic influences of warfarin dosage variability in the South African black population. Materials & methods: In this study, we genotyped 213 South African black individuals for CYP2C9 and VKORC1 variants and a small subset of environmental factors that may be responsible for warfarin dosage variability. Results: We observed 26 novel SNPs and seven previously described CYP2C9 variants and three previously described but no novel VKORC1 SNPs. Only 11 of the CYP2C9 variants and two of the VKORC1 variants were observed at high enough allele frequencies to assess their impact on warfarin dosage. Conclusion: We demonstrate that CYP2C9*8 and two novel CYP2C9 SNPs (g. 16179 and g. 46028) are associated with a decrease in warfarin dosage, beta-blockers are independently associated with a decrease in warfarin dosage and two known VKORC1 variants (rs7200749 and rs7294) are associated with an increase in warfarin dosage. The CYP2C9 and VKORC1 variants and a small subset of environmental factors used in the study explain approximately 45% of warfarin dosage variability in the South African black population.
引用
收藏
页码:953 / 963
页数:11
相关论文
共 50 条
  • [1] Effect of Genetic Variants, Especially CYP2C9 and VKORC1, on the Pharmacology of Warfarin
    Fung, Erik
    Patsopoulos, Nikolaos A.
    Belknap, Steven M.
    O'Rourke, Daniel J.
    Robb, John F.
    Anderson, Jeffrey L.
    Shworak, Nicholas W.
    Moore, Jason H.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2012, 38 (08) : 893 - 904
  • [2] Variability of warfarin dose response associated with CYP2C9 and VKORC1 gene polymorphisms in Chinese patients
    Ye, Changqing
    Jin, Haiqiang
    Zhang, Rui
    Sun, Yongan
    Wang, Zhaoxia
    Sun, Weiping
    Sun, Wei
    Peng, Qing
    Liu, Ran
    Huang, Yining
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2014, 42 (01) : 67 - 76
  • [3] The Influence of CYP2C9 and VKORC1 Gene Polymorphisms on the Response to Warfarin in Egyptians
    Bedewy, Ahmed M. L.
    Showeta, Salah
    Mostafa, Mostafa Hasan
    Kandil, Lamia Saeed
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2018, 34 (02) : 328 - 336
  • [4] The accuracy of warfarin dosage based on VKORC1 and CYP2C9 phenotypes in a Chinese population
    Wijaya, Agustinus
    Bo, Jiang T.
    Jun, He
    Ping, Jiang W.
    Bin, Jiang
    Jie, Chen H.
    Wen, Yang B.
    Zhu, Xu M.
    Cheng, Qiu Q.
    MEDICAL JOURNAL OF INDONESIA, 2012, 21 (02) : 108 - 112
  • [5] The impact of age and CYP2C9 and VKORC1 variants on stable warfarin dose in the paediatric population
    Vear, Susan I.
    Ayers, Gregory D.
    Van Driest, Sara L.
    Sidonio, Robert F.
    Stein, Charles Michael
    Ho, Richard H.
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 165 (06) : 832 - 835
  • [6] Polymorphisms of VKORC1 and CYP2C9 are associated with warfarin sensitivity in Chinese population
    Jia, LiQun
    Wang, Zanxin
    Men, Jianlong
    Cai, Heng
    Wei, Minxin
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2017, 13 : 421 - 425
  • [7] Effect of VKORC1 and CYP2C9 variants on dosage of oral anticoagulants in Chilean individuals
    Benavides, Felipe
    Grossman, Nicole
    Poggi, Helena
    Nieto, Elena
    Bertran, Antonio
    Araos, Daniel
    Vasquez, Marcos
    Ibarra, Ignaz
    Caceres, Felipe
    Espinoza, Karena
    Lagos, Marcel
    Repetto M, Gabriela
    REVISTA MEDICA DE CHILE, 2015, 143 (11) : 1369 - 1376
  • [8] Effect of CYP2C9 and VKORC1 Gene Variants on Warfarin Response in Patients with Continuous-Flow Left Ventricular Assist Devices
    Topkara, Veli K.
    Knotts, Robert J.
    Jennings, Douglas L.
    Garan, A. Reshad
    Levin, Allison P.
    Breskin, Alexander
    Castagna, Francesco
    Cagliostro, Barbara
    Yuzefpolskaya, Melana
    Takeda, Koji
    Takayama, Hiro
    Uriel, Nir
    Mancini, Donna M.
    Eisenberger, Andrew
    Naka, Yoshifumi
    Colombo, Paolo C.
    Jorde, Ulrich P.
    ASAIO JOURNAL, 2016, 62 (05) : 558 - 564
  • [9] VKORC1 and CYP2C9 polymorphisms are associated with warfarin dose requirements in Turkish patients
    Ozgon, G. Oner
    Langaee, T. Y.
    Feng, H.
    Buyru, N.
    Ulutin, T.
    Hatemi, A. C.
    Siva, A.
    Saip, S.
    Johnson, J. A.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 64 (09) : 889 - 894
  • [10] VKORC1 and CYP2C9 polymorphisms are associated with warfarin dose requirements in Turkish patients
    G. Oner Ozgon
    T. Y. Langaee
    H. Feng
    N. Buyru
    T. Ulutin
    A. C. Hatemi
    A. Siva
    S. Saip
    J. A. Johnson
    European Journal of Clinical Pharmacology, 2008, 64 : 889 - 894